OnKure Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
OnKure Therapeutics Depreciation & Amortization Growth & History (OKUR)
OnKure Therapeutics's depreciation and amortization was $447,000 for fiscal 2025.
View full OnKure Therapeutics company overviewOnKure Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $447,000 | −$12,000 | −2.61% |
| 2024 | 2024-12-31 | $459,000 | $42,000 | +10.07% |
| 2023 | 2023-12-31 | $417,000 | $329,000 | +373.86% |
| 2022 | 2022-12-31 | $88,000 | $38,000 | +76.00% |
| 2021 | 2021-12-31 | $50,000 | $13,000 | +35.14% |
| 2020 | 2020-12-31 | $37,000 | — | — |
OnKure Therapeutics quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $87,000 | −$30,000 | −25.64% |
| Q1 2026 | 2026-03-31 | $104,000 | −$14,000 | −11.86% |
| Q4 2025 | 2025-12-31 | $202,000 | — | — |
| Q3 2025 | 2025-09-30 | $108,000 | −$6,000 | −5.26% |
| Q2 2025 | 2025-06-30 | $117,000 | $2,000 | +1.74% |
| Q1 2025 | 2025-03-31 | $118,000 | $4,000 | +3.51% |
| Q3 2024 | 2024-09-30 | $114,000 | $71,000 | +165.12% |
| Q2 2024 | 2024-06-30 | $115,000 | $73,000 | +173.81% |
| Q1 2024 | 2024-03-31 | $114,000 | $73,000 | +178.05% |
| Q3 2023 | 2023-09-30 | $43,000 | $21,000 | +95.45% |
| Q2 2023 | 2023-06-30 | $42,000 | $20,000 | +90.91% |
| Q1 2023 | 2023-03-31 | $41,000 | $22,000 | +115.79% |
| Q3 2022 | 2022-09-30 | $22,000 | $9,000 | +69.23% |
| Q2 2022 | 2022-06-30 | $22,000 | $12,000 | +120.00% |
| Q1 2022 | 2022-03-31 | $19,000 | $9,000 | +90.00% |
| Q3 2021 | 2021-09-30 | $13,000 | $4,000 | +44.44% |
| Q2 2021 | 2021-06-30 | $10,000 | $1,000 | +11.11% |
| Q1 2021 | 2021-03-31 | $10,000 | $1,000 | +11.11% |
| Q3 2020 | 2020-09-30 | $9,000 | — | — |
| Q2 2020 | 2020-06-30 | $9,000 | — | — |
| Q1 2020 | 2020-03-31 | $9,000 | — | — |
OnKure Therapeutics depreciation and amortization trends
Over the last five fiscal years, OnKure Therapeutics's depreciation and amortization increased from $37,000 to $447,000, a change of $410,000. The latest reported quarter, Q2 2026, shows $87,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OnKure Therapeutics source filings ↗